A rapid, non-radioactive screening test for fragile X mutations at the FRAXA and FRAXE loci.

Screening of referrals for the mutations associated with the fragile X syndrome constitutes a significant workload in many genetics laboratories. Since the great majority of these referrals will be negative, there is a need for a rapid and inexpensive screening test. We have developed an assay which allows simultaneous amplification of the triplet repeat sequences at the FRAXA and FRAXE loci by polymerase chain reaction, and detection of the products on non-denaturing gels stained with ethidium bromide. Alleles of normal size are detected, leaving a small minority of samples to be tested by Southern blotting. A PCR based assay for detection of methylation at the CpG island upstream of the FMR-1 gene has also been devised.

[1]  K. Davies,et al.  Triplet repeat expansion at the FRAXE locus and X-linked mild mental handicap. , 1994, American journal of human genetics.

[2]  C. Mathew,et al.  Cytogenetic versus DNA diagnosis in routine referrais for fragile X syndrome , 1993, The Lancet.

[3]  W. Brown,et al.  Rapid Fragile X Carrier Screening and Prenatal Diagnosis Using a Nonradioactive PCR Test , 1993 .

[4]  K. Davies,et al.  Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation , 1993, Cell.

[5]  K. Davies,et al.  Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation. , 1993, Journal of medical genetics.

[6]  G. Sutherland,et al.  Characterisation of a new rare fragile site easily confused with the fragile X. , 1992, Human molecular genetics.

[7]  D. Nelson,et al.  Sixth international workshop on the fragile X and X-linked mental retardation. , 1992, American journal of medical genetics.

[8]  J. Sutcliffe,et al.  Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox , 1991, Cell.

[9]  N. Tommerup,et al.  Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. , 1991, The New England journal of medicine.

[10]  Ben A. Oostra,et al.  Absence of expression of the FMR-1 gene in fragile X syndrome , 1991, Cell.

[11]  J. S. Lee,et al.  Ethidium bromide does not fluoresce when intercalated adjacent to 7-deazaguanine in duplex DNA. , 1991, The Journal of biological chemistry.

[12]  R I Richards,et al.  Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n , 1991, Science.

[13]  J. Sninsky,et al.  Recent advances in the polymerase chain reaction , 1991, Science.

[14]  J. Sutcliffe,et al.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.

[15]  J. Mandel,et al.  Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome , 1991, Science.

[16]  M. Innis.  7 – PCR WITH 7-DEAZA-2′-DEOXYGUANOSINE TRIPHOSPHATE , 1990 .

[17]  J. Sambrook.  Preparation of reagents and buffers used in molecular cloning. , 1989 .

[18]  T. Webb,et al.  Population incidence and segregation ratios in the Martin-Bell syndrome. , 1986, American journal of medical genetics.

[19]  G. Holmgren,et al.  Prevalence of the fragile-X syndrome in mentally retarded boys in a Swedish county. , 1986, American journal of medical genetics.